PMV Pharmaceuticals Inc expected to post a loss of 35  cents a share - Earnings Preview

Pmv Pharmaceuticals

26/02/2022 03:02

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results on March
1 (estimated). 
    * ​Refinitiv's mean analyst estimate for PMV Pharmaceuticals
Inc
is for a loss of 35 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $59.5​, about 72.9% above​ its last
closing price of $16.14. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.30       -0.30      -0.33     Missed  -9.4
 Jun. 30 2021  -0.30       -0.28      -0.29     Missed  -2.8
 Mar. 31 2021  -0.24       -0.24      -0.26     Missed  -8.3​
 Dec. 31 2020              -0.57                        
 ​​Sep.        -0.34       -0.34      -1.46     Missed  -323.2
 30 2020                                                
                                                        ​
 This summary was machine generated February 26 at 03:01 GMT. 
All figures in US dollars  unless otherwise stated